Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.
Sponsored by Clalit Health Services
About this trial
Last updated 8 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 11 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- cough attributed to URTI such as the common cold
- 2-5 years of age
- moderate to severe day cough according to questionnaire (score at least 3 on all 3 questions relating to day cough) considering the day prior to enrollment.
- moderate to severe night cough score according to questionnaire (score at least 3 of 2 of the three questions relating to the evaluation of nocturnal cough (frequency of nocturnal cough, impact of the sleep of the child and impact on the sleep of the parent)
- signature of informed consent
Exclusion Criteria
- Children with the diagnosis of diseases of the lower respiratory tract: inflammation of the larynx, trachea, bronchi, pneumonia, asthma, sinusitis, allergic rhinitis, as well as heart disease.
- Children who received cough medicines or drugs containing antihistamines the day prior to study entry.
- Known hypersensitivity to honey or any other component of the experimental product such as Grindelia, Helichrysum, essential oils natural flavourings of Lemon, Sweet Orange, Myrtle; Lemon natural flavouring
- Children who received any steroid preparation (spray nozzle , or syrup , or other similar the day before study entry )
- Known sensitivity to carbocysteine specifically to the comparator Mucolit
- gastric ulcer